Su, Guo-Zhu, Li, Mi, Wang, Xiao-Jing, Wang, Ru-Bing, Ma, Shuang-Gang, Zhang, Dan, Wang, Xiao-Liang, Li, Li, Liu, Yun-Bao, Qu, Jing, Li, Yu-Huan, Li, Yong, Yu, Shi-Shan (2022): Chemical constituents from the fruits of Illicium simonsii and their antiviral activity and neuroprotective effect. Phytochemistry (113323) 202: 1-7, DOI: 10.1016/j.phytochem.2022.113323, URL: http://dx.doi.org/10.1016/j.phytochem.2022.11332
Fig. 9. Key 1H–1H COSY and HMBC correlations of compounds 11 12.Published as part of Zhang, Jian-Pei...
Fig. 10. Protection rate of resveratrol (RSV) and compounds 2–4, 6–9 and 11–16 against monosodium gl...
Fig. 10. Proposed biogenetic pathway for compounds 1–13.Published as part of Zhang, Jian-Pei, Li, We...
Fig. 1. The structures of compounds 1–11.Published as part of Su, Guo-Zhu, Li, Mi, Wang, Xiao-Jing, ...
Fig. 3. The ORTEP drawing of illisimonone A (1).Published as part of Su, Guo-Zhu, Li, Mi, Wang, Xiao...
Fig. 4. The experimental and calculated ECD spectra of 2a and 2b.Published as part of Su, Guo-Zhu, L...
Fig. 2. The key 2D NMR correlations of compounds 1–6.Published as part of Su, Guo-Zhu, Li, Mi, Wang,...
Fig. 5. The experimental ECD spectra of 3 and 4 and calculated ECD spectra of a pair of enantiomers ...
Zhang, Jian-Pei, Li, Wen-Rui, Wu, Shuo, Wang, Xiao-Jing, Wang, Ru-Bing, Li, Mi, Su, Guo-Zhu, Wang, H...
Fig. 3. Key ROESY and NOE correlations of compounds 1–5.Published as part of Zhang, Jian-Pei, Li, We...
<p>One new sesqui-neolignan compound, namely, sesqui-illisimonan A (<b>1</b>), one new neolignan, il...
Fig. 4. CD spectra of compounds 1–5, 7, 8, 10a, 11, 12, and 13 in MeOH.Published as part of Zhang, J...
Fig. 7. Key 1H–1H COSY, HMBC and NOEs/ROESY correlations of compounds 6–9.Published as part of Zhang...
Fig. 8. Key 1H–1H COSY, HMBC and ROESY correlations of compounds 10 and 10a.Published as part of Zha...
Fig. 2. Key HMBC correlations of compounds 1–5.Published as part of Zhang, Jian-Pei, Li, Wen-Rui, Wu...
Fig. 9. Key 1H–1H COSY and HMBC correlations of compounds 11 12.Published as part of Zhang, Jian-Pei...
Fig. 10. Protection rate of resveratrol (RSV) and compounds 2–4, 6–9 and 11–16 against monosodium gl...
Fig. 10. Proposed biogenetic pathway for compounds 1–13.Published as part of Zhang, Jian-Pei, Li, We...
Fig. 1. The structures of compounds 1–11.Published as part of Su, Guo-Zhu, Li, Mi, Wang, Xiao-Jing, ...
Fig. 3. The ORTEP drawing of illisimonone A (1).Published as part of Su, Guo-Zhu, Li, Mi, Wang, Xiao...
Fig. 4. The experimental and calculated ECD spectra of 2a and 2b.Published as part of Su, Guo-Zhu, L...
Fig. 2. The key 2D NMR correlations of compounds 1–6.Published as part of Su, Guo-Zhu, Li, Mi, Wang,...
Fig. 5. The experimental ECD spectra of 3 and 4 and calculated ECD spectra of a pair of enantiomers ...
Zhang, Jian-Pei, Li, Wen-Rui, Wu, Shuo, Wang, Xiao-Jing, Wang, Ru-Bing, Li, Mi, Su, Guo-Zhu, Wang, H...
Fig. 3. Key ROESY and NOE correlations of compounds 1–5.Published as part of Zhang, Jian-Pei, Li, We...
<p>One new sesqui-neolignan compound, namely, sesqui-illisimonan A (<b>1</b>), one new neolignan, il...
Fig. 4. CD spectra of compounds 1–5, 7, 8, 10a, 11, 12, and 13 in MeOH.Published as part of Zhang, J...
Fig. 7. Key 1H–1H COSY, HMBC and NOEs/ROESY correlations of compounds 6–9.Published as part of Zhang...
Fig. 8. Key 1H–1H COSY, HMBC and ROESY correlations of compounds 10 and 10a.Published as part of Zha...
Fig. 2. Key HMBC correlations of compounds 1–5.Published as part of Zhang, Jian-Pei, Li, Wen-Rui, Wu...
Fig. 9. Key 1H–1H COSY and HMBC correlations of compounds 11 12.Published as part of Zhang, Jian-Pei...
Fig. 10. Protection rate of resveratrol (RSV) and compounds 2–4, 6–9 and 11–16 against monosodium gl...
Fig. 10. Proposed biogenetic pathway for compounds 1–13.Published as part of Zhang, Jian-Pei, Li, We...